Zhao, Rui <br/><br/>
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.  [electronic resource] 

 -  The Journal of pharmacy and pharmacology  Apr 2011 
 - 550-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2042-7158 
<br/><br/><label>Standard No.: </label>10.1111/j.2042-7158.2010.01238.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--administration & dosage<br/>Administration, Oral<br/>Animals<br/>Antipyrine--analogs & derivatives<br/>Atrophy--prevention & control<br/>Behavior, Animal--drug effects<br/>Brain Injury, Chronic--complications<br/>Chromones--therapeutic use<br/>Cyclopropanes<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical<br/>Edaravone<br/>Free Radical Scavengers--therapeutic use<br/>Infarction, Middle Cerebral Artery--drug therapy<br/>Injections, Intraperitoneal<br/>Leukotriene Antagonists--pharmacology<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>Nerve Degeneration--drug therapy<br/>Quinolines--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sulfides